Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
N-butyl-2-cyanoacrylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Varices
1 trial -
NBP Softgel Capsules
The First People's Hospital of Lianyungang
Migraine
1 trial -
Nab-paclitaxel
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
Nadroparin Calcium and Warfarin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cirrhosis
1 trial -
Next generation sequencing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastrointestinal Cancer
1 trial -
Nitroprusside Sodium
The First People's Hospital of Lianyungang
ST Segment Elevation Myocardial Infarction
1 trial -
Norepinephrine
Shanghai Zhongshan Hospital
Gastrointestinal Disease
1 trial -
Norepinephrine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypotension
1 trial -
Normal Saline (Placebo)
The First People's Hospital of Lianyungang
Disease of Respiratory System
1 trial -
Nutrilite Protein MetX Pro
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Dyslipidemia
1 trial -
Nutrition Intervention
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Nutritional Supplement
Aspire Biopharma Holdings
Healthy
1 trial -
Nutritional therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cancer
1 trial -
OSS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Bowel Preparation
1 trial -
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial -
Olanzapine
Guangzhou Psychiatric Hospital
Schizophrenia
1 trial -
Oliceridine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypoxemia During Surgery
1 trial -
Omega-3
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Adhd
1 trial -
Omeprazole
Hospital Authority, Hong Kong
Gastroesophageal Reflux Disease
1 trial -
On-site radiologist
International Peace Maternity and Child Health Hospital
Tuberculosis
1 trial -
Only conventional drug therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pulmonary Artery Hypertension
1 trial -
Oral Oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy
2 trials -
Oral carbohydrate (Outfast)
The First People's Hospital of Lianyungang
Gastrointestinal Surgery
1 trial -
Oral fluid
Hospital Authority, Hong Kong
Osteoarthritis, Knee
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources